【摘 要】
:
NSC-631570 is the product of the reaction of different alkaloids from Chelidonium majus L.Numerous preclinical and clinical studies have proven its efficacy and safety (Ernst et al, 2005).The aim of t
【机 构】
:
Kyiv City Centre of Emergency Medical Care, Ukraine
【出 处】
:
BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会)
论文部分内容阅读
NSC-631570 is the product of the reaction of different alkaloids from Chelidonium majus L.Numerous preclinical and clinical studies have proven its efficacy and safety (Ernst et al, 2005).The aim of this study was to analyse the results of using NSC-631570 in treatment of children.A total of 203 advanced-stage cancer patients among them 14 children were treated with NSC-631570 in doses of 0.3 mg/kg 3 times a week for 3 week.80.3% of patients had remission (Aschhoffet al, 2000).5 children with severe stages of malignant tumors such as recurrent astrocytoma of the optic nerve, neuroblastoma, Ewings sarcoma, xeroderma pigmentosum and tuberous sclerosis with subependymal giant cell astrocytoma received NSC-631570 at various concentration as a monotherapy and in combination with hyperthermia and surgery.In all 5 children occurred complete or partial remission without side effects (Steinacker et al, 1996, Aschhoff et al, 1998, 2003, Nowicki et al, 2003).Considering that NSC-631570 also has immunomodulatory properties, safe for normal cells and its therapeutic index is 1250 (Sotomayor et al, 1992), was performed the studies of its efficacy in children with immunosuppressive conditions after Chernobyl disaster.38 children with recurrent respiratory diseases aged 3 to 14 years receive NSC-631570 in the total dose of 35 ml.The results of this study identify the immunomodulatory efficacy ofNSC-631570 (Zahriychuk,2003).Another study included a total of 40 children with recurrent bronchopulmonary disorders aged 7-18 years.It was identified the normalization of the clinical blood and respiratory parameters.Side effects of treatment were not available (Kazmirchuk et al 2003).So overall of 19 children with malignant tumors and 78 with recurrent respiratory diseases received the treatment with NSC-631570.The results were the complete and partial remission of disease, normalization the parameters of the immune system and clinical status of children.The negative effects ofNSC-631570 were absent.
其他文献
Background: Although S-1 plus cisplatin (SP) therapy is recognized as the standard treatment for advanced gastric cancer (AGC) in Japan, its safety and efficacy in elderly patients have not yet been i
The management of localised oesophageal and gastro-oesophageal (GO J) cancer has significantly evolved over last few years.Neo-adjuvant therapy is commonly employed to downstage the primary tumour and
Melanoma is an aggressive cancer, which is more prevalent among the white-skinned individuals.Apart from the skin;primary melanomas can involve the sites such as the mucosa eye and the leptomeninges.T
Colorectal cancer (CRC) is one of the most studied cancer in literature but controversial results are published about its pathogenesis, outcome, angiogenesis and molecular behavior.In our presentation
Ibritumomab tiuxetan (Zevalin) is currently indicated for the treatment of relapsed or refractory low grade or follicular B-cell Non-Hodgkins lymphoma (NHL), and previously untreated follicular NHL in
Search for innovative molecular biomarkers in a particular field is a big issue for the patients and also the medical and pharmaceutical industries.We will report our experience since our laboratory i
Itis known that the risk of bladder cancer in individuals with spinal cord injury (SCI) and indwelling catheter is higher (over 15 times) than in the general population.However, there are sporadic rep
Multiple myeloma (MM) is the most common hematological malignancy in Western countries.Although there are numerous effective treatments for MM today, these novel agents are often very expensive and in
Photodynamic therapy (PDT) is a dual therapeutic modality composed of a non toxic photo sensitizer (PS) and light of the appropriate wavelength.The PS is taken up to a high selectivity in malignant or
Cervical cancer is the second most common type of cancer (17.8 per 100,000 women) and cause of cancer deaths (9.8 per 100,000) among all types of cancer in women in developing countries.42 percent of